ClinicalTrials.gg
Not yet recruitingNCT06996977Updated May 30, 2025

Menstrual Cycle and Postanesthetic Shivering

An observational study in Postoperative Shivering, sponsored by Bozyaka Training and Research Hospital. Not yet recruiting at 1 site in Turkey. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-05-30.

Sponsored by Bozyaka Training and Research Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The goal of this observational study is to learn about the effect of menstrual cycle on postoperative shivering in women of fertile age. The main question it aims to answer is:

  • Do women in the luteal phase have less postoperative shivering? Participants will have their intraoperative body temperature recorded and will be observed for postanesthetic shivering, depending on whether they are in the luteal phase or follicular phase.
Read the detailed description

Postoperative shivering is a protective mechanism that the body uses to raise body temperature by rhythmic muscle contractions during hypothermia. Peroperative hypothermia is the most important cause of shivering after recovery. Shivering not only causes a decrease in patient comfort and discomfort but also increases metabolic demand by increasing oxygen consumption. This is an undesirable situation.

Women's hormonal status affects body temperature control. During the luteal phase, progesterone levels increase and this results in a 0.4 °C increase in core body temperature. The threshold for vasodilation also increases during this phase. Therefore, thermoregulation also changes during the luteal phase. Core body temperature in the follicular and luteal phase does not change with exposure to cold. However, under general anesthesia, core temperature is significantly reduced in both the luteal and follicular phase. Thermoregulatory vasoconstriction is less inhibited during luteal phase anesthesia.

The primary aim of our study was to determine the relationship between different phases of the menstrual cycle and the frequency of postoperative shivering. The secondary aim was to evaluate the incidence of intraoperative hypothermia and the duration of onset of intraoperative hypothermia in different phases of the menstrual cycle.

The study is planned as a prospective cross-sectional observational study. Female patients aged 18-45 years with ASA (American Society of Anesthesiology) score I-II who will undergo elective surgery for open technique septoplasty or rhinoplasty will be included in the study. They will be recorded in two groups as follicular group (F) and luteal group (L).

Patients data will be recorded;

  • Demographic data
  • Primary disease
  • Comorbidities
  • American Society of Anesthesiologists (ASA) Physical Status Classification
  • The phase of the menstrual cycle (luteal or follicular phase) according to the patient's medical history
  • Core body temperatures will be noted in the preoperative waiting area, before induction of general anesthesia, 1st hour under general anesthesia, 2nd hour under general anesthesia, 3rd hour under general anesthesia and in the postanesthetic recovery unit.
  • Anesthesia and duration of surgery
  • Infusion fluid quantity
  • Pain level in the postoperative recovery unit (numerical rating scale-NRS)
  • Postoperative tremors
  • PAS (postanesthetic shivering scale) value SPSS statistical program for Windows will be used for statistical analysis of the results. Considering the number of surgeries performed in previous periods, it was predicted that approximately 100 patients could be included in the study within this period. This period, which was determined to ensure homogeneous distribution of the groups, will be extended if necessary and more patients will be included in the study. Parametric descriptive values will be given as mean and standard deviation, and non-parametric values will be given as n (%) and median and IQR (interquartile range). The conformity of the data to normal distribution will be evaluated by one sample Kolmogorov-Smirnov test. Comparisons of quantitative data conforming to normal distribution will be made with Student T test and comparisons of data not conforming to normal distribution will be made with Mann Whitney U test. Chi-Square test will be used to compare qualitative data. For the analyses, the significance level will be accepted as p\<0.05 at 95% confidence interval.
02

Conditions studied

  • Postoperative Shivering

Keywords

  • menstrual cycle
  • core temperature
03

In context

Lead sponsor

Bozyaka Training and Research Hospital is the lead sponsor of 51 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Female patients scheduled for elective nose surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients undergoing elective open technical septoplasty or rhinoplasty
  • 18-45 years of age
  • I-II

Exclusion criteria

Exclusion Criteria:

  • Patient-legal representative does not want to be included in the study
  • Emergency surgery
  • Use of drugs that affect cardiovascular function, heat balance and hormone levels (e.g. combined oral )
  • Menstrual irregularity
  • Polycystic ovary syndrome
  • Thyroid disease
  • Autonomic disease
  • Reyno disease
  • Uncontrolled diabetes mellitus
  • Uncontrolled hypertension
  • Surgeries where the duration of anesthesia is less than 1 hour
  • Patients with NRS pain score above 7 in the recovery unit after anesthesia
  • Core body temperature below 36°C before induction of general anesthesia
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group follicular

    Follicular phase of menstrual cycle

  • Group luteal

    Luteal phase of menstrual cycle

06

What researchers measure

Primary outcomes

  1. Postoperative Shivering

    Postanesthetic shivering will be evaluated in the postanesthesia care unit by Postanesthetic Shivering Scale. The scale is a 5-points scale. 0= no shivering 1= no visible muscle activity but piloerection, peripheral vasoconstriction, or both are present (other causes excluded); 2 = muscular activity in only one muscle group; 3 = moderate muscular activity in more than one muscle group but no generalized shaking; 4 = violent muscular activity that involves the whole body. 3 and 4 mean worse outcome as the patient needs medication to treat shivering.

    Time frame: First 15 minutes after surgery

  2. Number of patients who require meperidine

    The need for intravenous meperidine administration when the postanesthetic shivering scale (PAS) of the patient is above 3.

    Time frame: first 15 minutes after surgery

Secondary outcomes

  1. Number of patients whose core body temperature is below 36 °C

    Intraoperative hypothermia is defined as a core body temperature below 36°C under anesthesia.

    Time frame: perioperative

  2. The time when intraoperative core body temperature is detected below 36 °C

    The time when the core body temperature is below 36°C during general anesthesia.

    Time frame: perioperative

07

Study locations

1 site
  • Izmir City Hospital
    Izmir, Bayraklı 35540, Turkey
    • Halide Şahinkaya, MD · Contactdrhhande@yahoo.com · +905058892157
    • Gözde Gürsoy Çirkinoğlu, MD · Contactdr.gozde.gursoy@gmail.com · +905544071757
    • Halide Hande ŞAHİNKAYA, MD · Principal investigator
    • Gözde GÜRSOY ÇİRKİNOĞLU, MD · Sub investigator
    • Tuba KUVVET YOLDAŞ, MD · Sub investigator
    • Volkan HANCI, MD · Sub investigator
08

References and documents

Publications

  • Simegn GD, Bayable SD, Fetene MB. Prevention and management of perioperative hypothermia in adult elective surgical patients: A systematic review. Ann Med Surg (Lond). 2021 Nov 14;72:103059. doi: 10.1016/j.amsu.2021.103059. eCollection 2021 Dec. PubMed 34840773 ↗
  • Tatsumi T, Sampei M, Saito K, Honda Y, Okazaki Y, Arata N, Narumi K, Morisaki N, Ishikawa T, Narumi S. Age-Dependent and Seasonal Changes in Menstrual Cycle Length and Body Temperature Based on Big Data. Obstet Gynecol. 2020 Oct;136(4):666-674. doi: 10.1097/AOG.0000000000003910. PubMed 32925608 ↗
  • 1. V. Erden, C. Güler, H. Bulut, N. Özsoy Toprak, and N. Uslu, "Menstrual cycle phase may effect the thermoregulation during anesthesia," International Journal of Anesthesia, vol. 5, 2018.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2025; primary completion for Aug 2025, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2025
First posted
May 30, 2025
StartEst.
Jun 1, 2025
Primary completionEst.
Aug 1, 2025
CompletionEst.
Aug 15, 2025
Last update
May 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06996977
Lead sponsor
Bozyaka Training and Research Hospital
Responsible party
Halide Hande Şahinkaya (Principal Investigator, Bozyaka Training and Research Hospital) — Principal investigator
First posted
May 30, 2025
Start date
Jun 1, 2025 (estimated)
Primary completion
Aug 1, 2025 (estimated)
Completion
Aug 15, 2025 (estimated)
Last update
May 30, 2025

Study contacts

Halide Hande Şahinkaya, MD
Contact
drhhande@yahoo.com
+905058892157
Gözde Gürsoy Çirkinoğlu, MD
Contact
dr.gozde.gursoy@gmail.com
+905544071757
Halide Hande ŞAHİNKAYA, MD
principal investigator · Izmir City Hospital
Gözde GÜRSOY ÇİRKİNOĞLU, MD
study chair · Izmir City Hospital
Tuba KUVVET YOLDAŞ, MD
study chair · Izmir City Hospital
Volkan HANCI, MD
study chair · 9 Eylul University Faculty of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion